A Randomized, Controlled Evaluation of the Safety and Efficacy of a Topical Treatment for Moderate-Severe Facial Acne Vulgaris.
Phase of Trial: Phase II
Latest Information Update: 30 Sep 2012
At a glance
- Drugs BLI 1100 (Primary)
- Indications Acne vulgaris
- Focus Therapeutic Use
- 26 Apr 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 07 Jan 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 23 Nov 2010 New trial record